Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01940835 · ClinicalTrials.gov registry record
Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 27
- Enrollment target
NCT01940835: Completed study, sponsored by Mayo Clinic.
NCT01940835 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01940835 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This purpose of this study is to determine if activation of a person's immune system in the small intestine could be a contributing cause of Type 1 Diabetes.
Interventions
- OTHER Blood draw
- OTHER Stool sample
- PROCEDURE Upper endoscopy with small bowel biopsies and brushings.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2013-09 |
| Est. Completion | 2019-06-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01940835
The ClinicalTrials.gov registry entry for NCT01940835 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT01940835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01940835 about?
NCT01940835 is a clinical study titled "Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes". This purpose of this study is to determine if activation of a person's immune system in the small intestine could be a contributing cause of Type 1 Diabetes.
What is the current status of trial NCT01940835?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2013-09. Estimated completion is 2019-06-19.
What interventions are being tested in trial NCT01940835?
The interventions under investigation include: Blood draw (OTHER), Stool sample (OTHER), Upper endoscopy with small bowel biopsies and brushings. (PROCEDURE).
Who is sponsoring clinical trial NCT01940835?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.